RTSA: A valid therapeutic option for geriatrics | All the latest medical news on the portal Medznat.ru. :- Medznat
EN | RU
EN | RU

Help Support

Back

RTSA: A valid therapeutic option for geriatrics

RTSA: A valid therapeutic option for geriatrics RTSA: A valid therapeutic option for geriatrics
RTSA: A valid therapeutic option for geriatrics RTSA: A valid therapeutic option for geriatrics

What's new?

In patients older than 80 years of age, reverse total shoulder arthroplasty (RTSA) has a low medical complication rate and an excellent improvement of shoulder pain and function.

A recent study illustrated that, despite a quite high postoperative complication rate, RTSA is a promising therapeutic choice, with an unexpectedly low medical complication rate and a good to excellent improvement of shoulder function and pain in patients older than 80 years of age.

A study was carried out to explore the outcome of primary RTSA in a patient cohort older than 80 years of age. Between January 2005 and March 2018, 171 shoulders (159 patients; 120 females), treated with an RTSA at an age of more than 80 years (mean age of 84 ±3 years) were recruited in this analysis.

Mortality, Subjective Shoulder Value (SSV) and the Constant-Murley Scores, complications, and reoperation rates were the primary endpoints. Adverse radiographic outcomes were the secondary outcome parameters. Due to the high patients' age, a minimum follow-up of 1 year was accepted in 14 patients.

Cuff tear arthropathy, isolated rotator cuff tear, and fracture were the main indications for RTSA.

136 (79%) were eligible for a physical examination and were followed-up for a mean period of 41±25 (minimum 12 to maximum 121) months.

An improvement in pain was witnessed. The relative constant scores and SSV improved remarkably, as shown in the following table:


The range of motion and force improved considerably. The surgical site complication rate was found to be 30%. The reoperation rate was found to be 8% (13 patients) primarily due to glenoid loosening and fracture. The mean time to death was 53 ± 31 months, and the overall mortality was found to be 16%.

The age-adjusted, expected mortality rate without this procedure was not found to higher.

Thus, in patients older than 80 years of age, RTSA is a significant therapeutic option as it can effectively alleviate pain, improve shoulder function, and possess a low medical complication rate. 

Source:

Journal of Shoulder and Elbow Surgery

Article:

Primary Reverse Total Shoulder Arthroplasty in Patients older than 80 years of age: Clinical and Radiological Outcome Measures

Authors:

Philipp Kriechling

Comments (0)

You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies en ru
Try: